Skip to main content

Table 2 Comparison of general information between Group A and Group B \(\overline{x}\) ± s, M (Q)

From: The benefit of exercise rehabilitation guided by 6-minute walk test on lipoprotein-associated phospholipase A2 in patients with coronary heart disease undergoing percutaneous coronary intervention: a prospective randomized controlled study

Variable

 

Group A

Group B

t (U) value

P value

N

49

46

BMI (kg/m2)

At baseline

24.04 ± 3.12

23.66 ± 3.76

0.538

0.592

 

After 12 weeks

24.23 ± 3.01

23.76 ± 3.70

0.671

0.504

TC (mmol/l)

At baseline

4.52 ± 1.28

4.40 ± 1.02

0.483

0.630

 

After 12 weeks

3.80 ± 0.89

3.85 ± 0.84

− 0.299

0.765

TG (mmol/l)

At baseline

1.37 ± 0.70

1.29 ± 0.54

0.598

0.551

 

After 12 weeks

1.58 ± 1.03

1.30 ± 0.71

1.508

0.135

Lp (a) (mmol/l)a

At baseline

16.90 (36.40)

13.40 (51.56)

976.000

0.780

 

After 12 weeks

15.50 (21.90)

13.94 (32.05)

1057

0.854

ApoA (g/l)

At baseline

1.31 ± 0.33

1.35 ± 0.26

− 0.711

0.479

 

After 12 weeks

1.37 ± 0.29

1.41 ± 0.28

− 0.758

0.451

ApoB (g/l)

At baseline

0.85 ± 0.23

0.86 ± 0.25

− 0.031

0.976

 

After 12 weeks

0.70 ± 0.20

0.70 ± 0.21

− 0.030

0.976

HDL-C (mmol/l)

At baseline

1.13 ± 0.29

1.17 ± 0.23

− 0.672

0.503

 

After 12 weeks

1.20 ± 0.29

1.27 ± 0.33

− 1.11

0.270

LDL-C (mmol/l)

At baseline

2.83 ± 1.09

2.75 ± 0.88

0.376

0.708

 

After 12 weeks

2.22 ± 0.69

2.08 ± 0.64

1.063

0.291

LP-PLA2 (umol/l)

At baseline

249.58 ± 129.24

221.37 ± 148.8

0.976

0.332

 

After 12 weeks

219.13 ± 117.70

155.87 ± 93.80*

2.875

0.005

  1. aMedian and quartile. M (Q) median (quartile), BMI body mass index, TC total cholesterol, TG three acyl glycerin, ApoA apolipoprotein A, ApoB apolipoprotein B, Lp (a) lipoprotein (a), LDL-C low density lipoprotein cholesterol, HDL-C high density lipoprotein cholesterol, LP-PLA2 Lipoprotein-associated Phospholipase A2. Compared between Group A and Group B
  2. *P < 0.05